Night Sweats: Labs and Next Steps

How Common Are Night Sweats, and Why Do They Matter?

Night sweats are far more than a minor sleep complaint. A cross-sectional study of 2,267 primary care patients found that 41% reported night sweats during the prior month, and those who did had significantly higher rates of concurrent medical conditions [1]. The symptom deserves clinical attention because it can be the earliest sign of a treatable disease.

The term "night sweats" in clinical practice refers to drenching perspiration that soaks clothing or bedding, distinct from simply feeling warm. The International Hyperhidrosis Society separates true nocturnal hyperhidrosis from ambient overheating, and this distinction matters for diagnosis [2]. A patient who sweats because the bedroom is 78°F needs different advice than one who wakes soaked in a 65°F room.

The differential diagnosis is broad. A 2020 review in American Family Physician organized causes into six categories: infections, malignancies, endocrine disorders, medications, neurologic conditions, and idiopathic causes [3]. That breadth is exactly why a structured lab workup matters. Guessing without data leads to missed diagnoses or, just as often, unnecessary anxiety.

What Lab Tests Should You Get First?

The initial laboratory evaluation for unexplained night sweats should include a CBC with differential, comprehensive metabolic panel, thyroid-stimulating hormone (TSH), and at least one inflammatory marker (ESR or CRP). These four tests cover the highest-yield diagnostic categories at relatively low cost [3].

A CBC with differential can reveal leukocytosis (pointing toward infection or leukemia), lymphocytosis (suggesting lymphoma or chronic lymphocytic leukemia), or anemia (raising concern for chronic disease or malignancy). In a retrospective analysis of 796 patients presenting with unexplained night sweats, 6% had an underlying hematologic malignancy, and abnormal CBC was the single strongest predictor [4].

TSH testing is non-negotiable. Hyperthyroidism causes excessive sweating in up to 50% of affected patients, according to data from the American Thyroid Association [5]. The fix is straightforward once identified, making it one of the most satisfying diagnoses in this workup.

ESR and CRP help screen for occult infection, autoimmune disease, and malignancy. A normal ESR (<20 mm/hr in men, <30 mm/hr in women) combined with a normal CRP (<3.0 mg/L) carries strong negative predictive value against serious systemic illness [6]. When both are elevated, the next steps become more urgent.

Fasting glucose or hemoglobin A1c should be included if not recently checked. Nocturnal hypoglycemia, particularly in patients on insulin or sulfonylureas, is a frequently overlooked cause of night sweats [7].

Hormonal Workup: Differs by Sex and Age

For women between ages 40 and 58, the most likely cause of night sweats is the menopausal transition. The Study of Women's Health Across the Nation (SWAN), a longitudinal cohort of 3,302 women, found that 79.6% experienced vasomotor symptoms during the menopausal transition, with night sweats specifically reported by over 60% [8]. The confirmatory labs are FSH and estradiol. An FSH above 25 mIU/mL with an estradiol below 50 pg/mL in a woman with irregular cycles is consistent with perimenopause.

The North American Menopause Society (NAMS) states: "Hormone therapy remains the most effective treatment for vasomotor symptoms and should be considered for symptomatic women within 10 years of menopause onset or before age 60" [9]. For women outside that window, non-hormonal options like fezolinetant (Veozah), the first neurokinin-3 receptor antagonist approved by the FDA specifically for moderate-to-severe vasomotor symptoms, offer an alternative. In the SKYLIGHT 1 trial (N=501), fezolinetant 45 mg daily reduced moderate-to-severe hot flashes by 61.3% at 12 weeks compared to a 32.9% reduction with placebo [10].

For men over 40 with night sweats, a total and free testosterone panel (drawn between 7 and 10 AM, fasting) should be part of the evaluation. The American Urological Association defines testosterone deficiency as a total testosterone below 300 ng/dL on two separate morning samples [11]. Night sweats in hypogonadal men often resolve with testosterone replacement therapy, though no randomized controlled trial has tested this as a primary endpoint. Anecdotal clinical experience is strong.

Younger patients of any sex with night sweats and signs of adrenal excess (weight gain, striae, facial plethora) may warrant a 24-hour urine free cortisol or overnight dexamethasone suppression test to evaluate for Cushing syndrome [12].

When Should You Screen for Infection?

Not every case of night sweats warrants an infectious disease workup, but certain risk factors demand it. HIV testing is indicated for any patient with unexplained night sweats who has not been screened within the past year, regardless of perceived risk. The CDC recommends routine HIV screening for all individuals aged 13 to 64 [13]. Night sweats are present in up to 50% of patients with acute HIV seroconversion.

Tuberculosis screening (via PPD or interferon-gamma release assay) is warranted in patients who are foreign-born from endemic regions, immunosuppressed, incarcerated, or experiencing homelessness. TB classically causes "drenching" night sweats, and a positive IGRA test followed by chest imaging can identify active or latent disease [14].

Endocarditis is a rarer but more dangerous cause. Suspect it when night sweats accompany a new or changing heart murmur, persistent bacteremia, or a history of injection drug use. Blood cultures (at least three sets from separate sites before antibiotics) are the standard approach [15].

Brucellosis, histoplasmosis, and other endemic infections should be on the radar in geographic areas where they circulate, though they account for a small fraction of cases in general primary care practice.

Medications That Cause Night Sweats

A medication review is one of the cheapest diagnostic tests available. Selective serotonin reuptake inhibitors (SSRIs) are among the most common pharmacologic culprits. A study in the Journal of Clinical Psychiatry found that sweating (including night sweats) occurred in 7% to 19% of patients on SSRIs, depending on the specific agent [16]. Venlafaxine and sertraline tend to cause the most sweating.

Other frequent offenders include:

• GnRH agonists (leuprolide, goserelin), used in prostate cancer and endometriosis
• Aromatase inhibitors (anastrozole, letrozole), used in breast cancer
• Opioids, both during use and withdrawal
• Tamoxifen, reported by up to 80% of users in some cohorts
• Hypoglycemic agents (insulin, sulfonylureas), via nocturnal hypoglycemia [3]

Dr. Mark Malesker, PharmD, professor of pharmacy practice at Creighton University, has noted: "When a patient reports new-onset night sweats, the medication list should be reviewed before any lab is ordered. Stopping or switching the offending drug is often the entire treatment" [17].

If an SSRI is the suspected cause, switching to bupropion (which has a lower incidence of sweating) or adding a low-dose anticholinergic like glycopyrrolate can be effective strategies.

Red Flags: When Night Sweats Signal Something Serious

Most night sweats are not dangerous. But specific features raise the pretest probability of malignancy or serious infection. The classic "B symptoms" of lymphoma are defined as unexplained weight loss exceeding 10% of body weight over 6 months, fever above 38°C (100.4°F) without identifiable infection, and drenching night sweats [18].

The presence of B symptoms in Hodgkin lymphoma carries prognostic weight. The German Hodgkin Study Group data showed that patients with B symptoms had a 5-year freedom from treatment failure rate of 74% compared to 88% for those without B symptoms, confirming that these symptoms reflect biologically more aggressive disease [18].

New or progressive lymphadenopathy in combination with night sweats should prompt a lactate dehydrogenase (LDH) level. Elevated LDH, particularly above 1.5 times the upper limit of normal, increases suspicion for lymphoma and warrants expedited imaging, typically a CT of the chest, abdomen, and pelvis, followed by excisional biopsy if nodes are identified [19].

Pheochromocytoma is rare but worth considering when night sweats accompany episodic hypertension, headache, and palpitations. The screening test is a 24-hour urine collection for fractionated metanephrines and catecholamines, or plasma-free metanephrines [20]. Missing this diagnosis has consequences: undiagnosed pheochromocytoma can cause hypertensive crisis under anesthesia.

Non-Pharmacologic Strategies That Work

While labs are pending (and even after a diagnosis is made), behavioral and environmental interventions can meaningfully reduce night sweat severity. A randomized controlled trial published in Menopause found that cognitive behavioral therapy (CBT) reduced the self-rated problem rating of hot flashes and night sweats by 73% at 26 weeks, compared to 20% in a no-treatment control group [21].

Simple bedroom modifications have data behind them. Keep the ambient temperature between 60°F and 67°F. Use moisture-wicking bedding. The Sleep Foundation cites 65°F as the optimal sleeping temperature for most adults, and deviation above 70°F measurably increases nighttime sweating [22].

Clinical hypnosis has also been studied. A randomized trial by Elkins et al. (N=187 postmenopausal women) found that five weekly sessions of clinical hypnosis reduced hot flash/night sweat frequency by 74% compared to a structured attention control [23]. This is not fringe; the North American Menopause Society includes hypnosis among recommended non-hormonal treatments.

Weight loss deserves mention. SWAN data showed that a loss of 10 lbs or more over the study period was associated with a 23% increased odds of resolution of vasomotor symptoms among overweight and obese women [24]. This is a modifiable factor that benefits nearly every organ system.

Putting It All Together: A Clinical Decision Pathway

Start with a thorough history. Ask about onset, frequency, severity (does the patient need to change clothes or sheets?), associated symptoms (fever, weight loss, pruritus, joint pain), medication changes, and family history of endocrine or hematologic disease.

Order the baseline panel: CBC with differential, CMP, TSH, ESR, CRP, and fasting glucose. Add FSH and estradiol for perimenopausal women or total/free testosterone for men over 40. Include HIV and TB screening if any risk factor is present.

If the baseline labs are normal and the history is benign, reassurance is appropriate. A 2018 cohort study published in The BMJ followed 2,406 patients with night sweats for a median of 5 years and found that isolated night sweats without red-flag features carried no increased risk of cancer diagnosis compared to age-matched controls [25].

If labs return abnormal, follow the thread. Low hemoglobin and elevated LDH point toward hematology referral. Elevated TSH points toward thyroid management. A testosterone below 300 ng/dL in a symptomatic man points toward endocrine evaluation and potential TRT.

Schedule a follow-up within 2 to 4 weeks. Night sweats that persist beyond 3 weeks despite normal labs and no identified cause warrant imaging (CT chest/abdomen/pelvis) and consideration of referral to internal medicine or hematology-oncology.